Hodac News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hodac. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hodac Today - Breaking & Trending Today

ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy

Kenneth C. Anderson, MD, discusses the recent ODAC decisions for ide-cel and cilta-cel, highlighting clinical trial data supporting the indications. ....

United States , Kennethc Anderson , Oncologic Drugs Advisory Committee , Bristol Myers Squibb , Meeting Of The Oncologic Drugs Advisory Committee , Drugs Advisory Committee , Dana Farber Cancer Institute , Decabtagene Vicleucel Ide Cel Abecma , Ciltacabtagene Autoleucel Cilta Cel Carvykti ,

FDA's ODAC Recognizes MRD as an Accepted End Point for Accelerated Approval in Multiple Myeloma

The FDA’s ODAC voted that data support the use of minimal residual disease as an end point to support accelerated approval of treatments in multiple myeloma. ....

Ravia Madan , University Of Miami Sylvester Comprehensive Cancer Center , University Of Miami , National Cancer Institute , Oncologic Drugs Advisory Committee , Drugs Advisory Committee , Sylvester Comprehensive Cancer Center , Multiple Myeloma , Minimal Residual Disease ,

FDA adcom backs MRD as new endpoint in multiple myeloma trials

By a unanimous 12-0 vote, the U.S. FDA’s Oncologic Drugs Advisory Committee concluded that new evidence support the use of minimal residual disease (MRD) as an accelerated approval endpoint in multiple myeloma (MM) clinical trials. ....

Oncologic Drugs Advisory Committee , Drugs Advisory Committee , Multiple Myeloma , Minimal Residual Disease ,

Targeted Pulse: Social Determinants Link to Cervical Cancer, FDA News, and More

This week's Targeted Pulse focuses on the latest in cervical cancer, the FDA ODAC's vote for cilta-cel, and more.

....

United States , New Orleans , Tremelimumab Imjudo , Tanya Siddiqi , Solange Peters , Rob Sokolic , Tara Castellano , Department Of Oncology , Thoracic Malignancies Programme , University Hospital Of Lausanne , Oncologic Drug Advisory Committee , Bristol Myers Squibb , Office Of Therapeutic Products , Office Of Clinical Evaluation , Bristol Myers , Cervical Cancer Geo Analyzer , Gynecologic Oncology , Louisiana State University , Medical Oncology , University Hospital , Hope Orange County , Drug Advisory Committee , Clinical Evaluation , Therapeutic Products , Biologics Evaluation , Targeted Pulse ,

Lab to lifesaver: UH research powers medical breakthroughs | University of Hawaiʻi System News

The FDA panel announced a breakthrough and approved the use of eflornithine in adult and pediatric patients with neuroblastoma. ....

Naoto Ueno , Naotot Ueno , University Of Hawai , Drug Administration , Michigan State University , Cancer Center , Uh Cancer Center , Michigan State , Uh Manoa , Manoa Research , Andres Bachmann , Food And Drug Administration , Uh Hilo , Oncologic Drugs Advisory Committee , University Of Hawaii At Manoa , Manoa Campus , Manoa University , Manoa College , Public Impact Research ,